Skip to main content
SpringerLink
Log in

A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background. Recently, granulocyte and monocyte adsorption apheresis (GMA) has been shown to be effective for active ulcerative colitis (UC). Its original weekly treatment schedule is effective in about 70% of active UC. However, it takes about 3–4 weeks to achieve remission, and the efficacy of a more frequent treatment schedule has not been elucidated yet. We performed a pilot open-labeled prospective, randomized, controlled study comparing weekly and an intensive treatment schedule with three treatment sessions per week in the first 2 weeks. Methods. Thirty active UC patients with moderate disease activity were prospectively and randomly assigned to receive the original or the intensive treatment schedule for a total of ten sessions. The proportion of the patients achieving remission and the time to achieve remission among them was compared between the two groups. The incidences of adverse effects were also compared between the two groups. Results. The rate of inducing remission in the original and intensive treatment group was 66.7% and 80%, respectively (P = 0.25, NS). The time to achieve remission was 27.2 days in the original group and 10.7 days in the intensive group (P = 0.04). Adverse effects were observed in two patients in each groups (NS). Conclusions. Intensive treatment with GMA is an efficacious and safe treatment for active UC. Because it induces rapid remission, it may be a more ideal treatment regimen than the conventional weekly treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417–29.

    Article  PubMed  CAS  Google Scholar 

  2. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006;41:10–6.

    Article  PubMed  Google Scholar 

  3. Hibi T, Sakuraba A. Is there a role for apheresis in gastrointestinal disorders? Nat Clin Pract Gastroenterol Hepatol 2005;2:200–1.

    Article  PubMed  Google Scholar 

  4. Bicks RO, Groshart KD. The current status of T-lymphocyte apheresis (TLA) treatment of Crohn’s disease. J Clin Gastroenterol 1989;11:136–8.

    Article  PubMed  CAS  Google Scholar 

  5. Shimoyama T, Sawada K, Hiwatashi N, Sawada T, Matsueda K, Munakata A, et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study. J Clin Apher 2001;16:1–9.

    Article  PubMed  CAS  Google Scholar 

  6. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004;49:565–71.

    Article  PubMed  CAS  Google Scholar 

  7. Hanai H, Watanabe F, Takeuchi K, Iida T, Yamada M, Iwaoka Y, et al. Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study. Clin Gastroenterol Hepatol 2003;1;28–35.

    Article  PubMed  Google Scholar 

  8. Naganuma M, Funakoshi S, Sakuraba A, Takagi H, Inoue N, Ogata H, et al. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis. Inflamm Bowel Dis 2004;10:251–7.

    Article  PubMed  Google Scholar 

  9. Fukuda Y, Matsui T, Suzuki Y, Kanke K, Matsumoto T, Takazoe M, et al. Adsorptive granulocyte and monocyte apheresis for refractory Crohn’s disease: an open multicenter prospective study. J Gastroenterol 2004;39:1158–64.

    Article  PubMed  Google Scholar 

  10. Nagashima M, Yoshino S, Tanaka H, Yoshida N, Kashiwagi N, Saniabadi AR. Granulocyte and monocyte apheresis suppresses symptoms of rheumatoid arthritis: a pilot study. Rheumatol Int 1998;18:113–8.

    Article  PubMed  CAS  Google Scholar 

  11. Garland CF, Lilienfeld AM, Mendeloff AI, Markowitz JA, Terrell KB, Garland FC. Incidence rates of ulcerative colitis and Crohn’s disease in fifteen areas of the United States. Gastroenterology 1981;81:1115–24.

    PubMed  CAS  Google Scholar 

  12. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841–5.

    Article  PubMed  CAS  Google Scholar 

  13. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804–10.

    PubMed  CAS  Google Scholar 

  14. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J 1964;1:89–92.

    Article  PubMed  CAS  Google Scholar 

  15. Mahida YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis 2000;6:21–33.

    Article  PubMed  CAS  Google Scholar 

  16. Lampinen M, Carlson M, Sangfelt P, Taha Y, Thorn M, Loof L, et al. IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig Dis Sci 2001;46:2004–9.

    Article  PubMed  CAS  Google Scholar 

  17. Kashiwagi N, Nakano M, Saniabadi AR, Adachi M, Yoshikawa T. Anti-inflammatory effect of granulocyte and monocyte adsorption apheresis in a rabbit model of immune arthritis. Inflammation 2002;26:199–205.

    Article  PubMed  Google Scholar 

  18. Kashiwagi N, Sugimura K, Koiwai H, Yamamoto H, Yoshikawa T, Saniabadi AR, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002;47:1334–41.

    Article  PubMed  CAS  Google Scholar 

  19. Sawada K, Kusugami K, Suzuki Y, Bamba T, Munakata A, Hibi T, et al. Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment. Am J Gastroenterol 2005;100:1362–9.

    Article  PubMed  Google Scholar 

  20. Muratov V, Lundahl J, Ulfgren AK, Elvin K, Fehrman I, Ahlborg N, et al. Down-regulation of interferon-gamma parallels clinical response to selective leukocyte apheresis in patients with inflammatory bowel disease: a 12-month follow-up study. Int J Colorectal Dis 2006;21:493–504.

    Article  PubMed  CAS  Google Scholar 

  21. Domenech E, Hinojosa J, Esteve-Comas M, Gomollon F, Herrera JM, Bastida G, et al. Granulocyte aphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther 2004;20:1347–52.

    Article  PubMed  CAS  Google Scholar 

  22. Rowe FA, Walker JH, Karp LC, Vasiliauskas EA, Plevy SE, Targan SR. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. Am J Gastroenterol 2000;95:2000–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku,Tokyo, 160-8582, Japan

    Atsushi Sakuraba, Toshiro Sato, Makoto Naganuma, Yuichi Morohoshi, Katsuyoshi Matsuoka, Nagamu Inoue, Hiromasa Takaishi, Haruhiko Ogata, Yasushi Iwao & Toshifumi Hibi

Authors
  1. Atsushi Sakuraba
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshiro Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Makoto Naganuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yuichi Morohoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katsuyoshi Matsuoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nagamu Inoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiromasa Takaishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Haruhiko Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yasushi Iwao
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Toshifumi Hibi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakuraba, A., Sato, T., Naganuma, M. et al. A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis. J Gastroenterol 43, 51–56 (2008). https://doi.org/10.1007/s00535-007-2129-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-007-2129-6

Key words

Search

Navigation